Plant-based “vaccine” uses herbs to activate the immune system against the coronavirus, without the blood clot risk

[ivory-search id="2380" title="Default Search Form"]

(Natural News) Canadian company Medicago has developed a plant-based vaccine for the Wuhan coronavirus (COVID-19). The two-dose vaccine uses virus-like particles (VLP) grown in a tobacco shrub to confer immunity against COVID-19.

VLPs are molecules that closely resemble a virus. They are not infectious since they do not contain genetic material. Vaccines that use VLPs train the immune system to recognize a virus and launch an attack if a person gets infected.

Medicago’s vaccine is different from all authorized COVID-19 vaccines. Whereas other vaccines target only the spike protein, the molecule used by the coronavirus to infect host cells, the plant-based shot uses VLPs that resemble the overall structure of the Wuhan coronavirus.

A small Phase 1 study shows that recipients of the vaccine produce 10 times as many antibodies as people who have had COVID-19. The data also indicate no links to blood clots, which have been reported in people inoculated with the Johnson & Johnson and AstraZeneca vaccines.

“Thus far, the safety profile from the Medicago pre-clinical data as well as the Phase 1 and Phase 2 data has identified nothing concerning regarding blood clotting or any other safety flags,” Dr. Mark Carlson, the principal investigator for Be Well Clinical Studies, the Nebraska arm of the trial, told KETV.

The vaccine can be distributed easily since it does not have to be stored at freezing temperatures. In addition, it can be manufactured quickly for less than the cost of other vaccines, according to Dr. Matthew Hong of Wake Research in North Carolina, which is also conducting trials for Medicago.

“All you have to do is extract the spike protein from the plant from the leaves, and you have the vaccine,” Hong told ABC News 11. “You don’t need all the background and all the other support systems.”

The firm is currently recruiting 30,000 volunteers for a late-stage trial. To qualify, volunteers must be aged 18 years or older and have not had or been vaccinated for COVID-19. This is increasingly difficult because around 50.7 percent of the adult American population has received at least one dose.

“Our pool of potential subjects is shrinking daily, and so Medicago is trying to amplify this trial as quickly as possible,” Carlson said. The firm hopes to have the results by fall for submission to American drug regulators. (Related: America has NO PLAN for coronavirus other than a vaccine – what about nutrition and herbs?.)

Herbs for treating the coronavirus

Researchers are also looking into herbs to treat COVID-19. In Thailand, healthcare providers have been using an extract of the Asian plant fah talai jone to treat mild to asymptomatic infections. Multiple patients have recovered from the disease after taking the herbal extract for just five days.

Also known as green chiretta or Andrographis paniculata, the herb has been used for centuries in Ayurveda and Traditional Chinese Medicine to treat lung infections. Its antiviral properties are attributed to the compound andrographolide, which also has antioxidant, anti-inflammatory and anticancer properties.

In a study last April, Thai researchers treated six COVID-19 patients with 180 milligrams of andrographolide. All participants had mild symptoms, such as sore throat, headache, cough and runny nose.

Each participant’s condition improved after three days, and their symptoms were gone after five. In addition, none of the participants experienced any side effects.

“We are confident that fah talai jone can cure COVID-19 patients who have mild symptoms and are asymptomatic,” said Dr. Kwanchai Wisitthanon, the director-general of the Department of Thai Traditional and Alternative Medicine, which led the study.

Last December, Thailand’s Ministry of Public Health approved the use of the extract for treating the early stages of COVID-19. The use of the herbal treatment was on a voluntary basis and was available only for people between the ages of 18 to 60 years who exhibited minor symptoms. It should be administered within three days of confirming an infection, the ministry said.

PlantMedicine.news has more on herbal treatments for COVID-19.

Newest Posts

Archives

0 Comments

Related Posts

CALL TO ACTION  9-11-2021 IT’S TIME TO TAKE A STAND

CALL TO ACTION 9-11-2021 IT’S TIME TO TAKE A STAND

Ethics Professor Giving One Last Lesson On COVID Vaccines! She Is Resigning After This.How Many Are Actually Declared Dead Within The First Two Weeks? 200,000 Died After Being Vaccinated, Within The First Two Weeks!DON'T ACCEPT ANY MORE LIES!

Do You Even Know What You Are Getting? Surprize

Do You Even Know What You Are Getting? Surprize

What Are The Real Ingredients?WE Are The Real Ginnie Pigs?Wow, Our Bodies Can Make Anything?What Are The Real Consequences And Possible Side AffectsEven The Tests Have Possible Side AffectsFire Fauci Act!Plan B After COVID Fails!Plan COVID Vaccine Is Shear Madness!...

We Are In The Last Battle – Hold The Line

We Are In The Last Battle – Hold The Line

Time To Take Our Country Back!All Aboard The Storm Has Arrived!Resucing Children From Human Trafficing In Mo. July 4, 2021Something Went Big Bada Boom In The Caspean Sea! 7-5-2021Even Mark Zuckerberg Can't Win Against Us. Look At His 4th Of July Outing!

V FOR VENDETTA SPEACH TO THE PEOPLE

V FOR VENDETTA SPEACH TO THE PEOPLE

Let's take a break from everyday life and have a little chat. Of course, there will be those, who do not want our communication. They can forbid it. But they cannot forbid words. Words illuminate the truth to those, who listen to them. And the truth is simple -...